Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis
about
Cytotoxic clinical isolates of Pseudomonas aeruginosa identified during the Steroids for Corneal Ulcers Trial show elevated resistance to fluoroquinolones.Signaling Mediated by Toll-Like Receptor 5 Sensing of Pseudomonas aeruginosa Flagellin Influences IL-1β and IL-18 Production by Primary Fibroblasts Derived from the Human CorneaInterleukin 17 regulates Mer tyrosine kinase-positive cells in Pseudomonas aeruginosa keratitis.Surfactant protein D contributes to ocular defense against Pseudomonas aeruginosa in a murine model of dry eye disease.Pseudomonas aeruginosa utilizes the type III secreted toxin ExoS to avoid acidified compartments within epithelial cellsTranslocon-independent intracellular replication by Pseudomonas aeruginosa requires the ADP-ribosylation domain of ExoS.Microbial keratitis: could contact lens material affect disease pathogenesis?Inactivation of the miR-183/96/182 Cluster Decreases the Severity of Pseudomonas aeruginosa-Induced Keratitis.Dry eye disease and microbial keratitis: is there a connection?Pseudomonas aeruginosa Outer Membrane Vesicles Triggered by Human Mucosal Fluid and Lysozyme Can Prime Host Tissue Surfaces for Bacterial Adhesion.Why does the healthy cornea resist Pseudomonas aeruginosa infection?Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa KeratitisThrombomodulin Protects Against Bacterial Keratitis, Is Anti-Inflammatory, but Not Angiogenic.Fungi associated with drug recalls and rare disease outbreaks.Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.A proof-of-concept model for the identification of the key events in the infection process with specific reference to Pseudomonas aeruginosa in corneal infections.Strategies for the prevention of contact lens-related Acanthamoeba keratitis: a review.IL-24 Promotes Pseudomonas aeruginosa Keratitis in C57BL/6 Mouse Corneas.Geographic Disparities in the Etiology of Bacterial and Fungal Keratitis in the United States of America.Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.Paediatric infectious keratitis at tertiary referral centres in Vancouver, Canada.Fibrous Catalyst-Enhanced Acanthamoeba Disinfection by Hydrogen Peroxide.Effect of Different Antibiotic Chemotherapies on Pseudomonas aeruginosa Infection In Vitro of Primary Human Corneal Fibroblast Cells.Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.Epidemiological, clinical and laboratory findings of infectious keratitis at Mansoura Ophthalmic Center, Egypt.Methods for In Vivo/Ex Vivo Analysis of Antimicrobial Peptides in Bacterial Keratitis: siRNA Knockdown, Colony Counts, Myeloperoxidase, Immunostaining, and RT-PCR Assays.Tripartite Motif 8 (TRIM8) Positively Regulates Pro-inflammatory Responses in Pseudomonas aeruginosa-Induced Keratitis Through Promoting K63-Linked Polyubiquitination of TAK1 Protein.Levofloxacin and Tobramycin for Severe Bacterial Keratouveitis.A Rabbit Model of Acanthamoeba Keratitis That Better Reflects the Natural Human Infection.Contact lenses for ophthalmic drug delivery.Pharmacological treatment for infectious corneal ulcers.Contributions of MyD88-dependent receptors and CD11c-positive cells to corneal epithelial barrier function against Pseudomonas aeruginosa.Seeing red: over-the-counter chloramphenicol.Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.Designed Host Defense Peptides for the Treatment of Bacterial Keratitis.Bacterial profile of ocular infections: a systematic review.Characterization of antibiotic and disinfectant susceptibility profiles among Pseudomonas aeruginosa veterinary isolates recovered during 1994-2003.Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin.Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective.Clinical and microbiological profile of Pseudomonas aeruginosa keratitis admitted to a New Zealand tertiary centre.
P2860
Q33559958-3280D1B0-D7B7-482C-AF60-D608628472FAQ33575981-3FB7144F-7227-4B00-936B-71CE43102BBAQ34426338-3BA3F257-2322-451D-9D10-AD81EF7F3976Q34770248-C979ECDB-1404-4F67-BF62-FAA356F6EED5Q34994298-58A71FA2-F7B3-4BDA-A75F-789E4F3BB9E5Q36467990-8058888D-D56D-4BCE-B0F6-DA5EB56DAB61Q36514233-0192E029-FC71-4F34-BC49-F5A6F3EFC772Q36761354-B6A76751-E6EF-47F3-855C-1A97F10C362FQ36799601-E14413F5-E749-4E66-9016-114296010BA3Q36963916-025F5730-BC19-431A-AB31-CE29A5D36A17Q37032684-DF660F85-9B14-495E-A214-226FD98A3B3DQ37384368-2B24DB11-A0FE-4D92-8F10-CEE2127AB91EQ37415586-05B5BBD5-CC60-4D1E-B6CD-ED44211FA873Q38244886-2E29F1BB-9D4A-45E0-9B45-BED9FFE596F5Q38625299-DC7FA469-7761-49B1-908E-7DD1F956BC73Q38627617-6E27CE88-F9A9-4392-92CE-79FDDA488BD3Q38675542-585C75B6-ABC6-4A4E-BB52-1422081F54C6Q38711141-26F76C65-C2E7-440D-8D21-B8A4BD8409C0Q38814113-265D36AC-75B1-47AC-A516-CF03E760A99BQ39163677-A76F2464-72E9-49E5-956A-21755A8021CEQ39876154-72ADAB66-0083-458E-B44E-5B4F7A7501E8Q40049475-409E5642-43FC-4921-AEE5-6DBBFA6A07E9Q40063500-1D6A4726-D58D-4663-813F-07370EA418DCQ40216978-A2B4D0CF-D176-404E-B84C-A6D6486FA732Q40349351-AC9EAA03-DB68-4FA1-81ED-F82EF3DF9382Q40396065-20A0EB2B-CA1D-4696-A4E4-7FB78E771BAFQ40403116-26A3D89E-078F-4636-9D39-EEAB4ED45BFEQ41109164-28CCC570-EBD7-4354-A5EB-1700EC97BC9CQ41434252-6C0D873F-FE72-4AA8-84E9-7F6E5D0CE817Q41994984-3BF51D8E-D64D-4194-8D72-D896E4C4FE82Q42273313-0672BF39-7241-47DE-BE2A-879578CFF581Q42645252-E4DA93DA-3D00-4A0D-9AC9-A32429BE55EBQ45227464-AACAFEE5-2083-463C-881A-228F781CE667Q45259980-89E74BA6-BB81-40EB-8AD4-54B3BE7D820EQ46683772-7B235DB9-3432-4B97-8FC9-3801C05A7132Q46747284-66ACA9A0-EEBE-4E03-ACAB-5EEADC8DA8F1Q46809440-92C8C997-8376-4108-8C4E-813C54451FA2Q47448907-206E9C72-B9EA-4C71-8B53-0AA69B28527FQ47769461-EDE452A5-6E6E-4430-873D-ACD736522D9FQ48155141-C6BB44A8-71EB-45F8-B95B-8B605BB08840
P2860
Contact lens-related microbial keratitis: how have epidemiology and genetics helped us with pathogenesis and prophylaxis
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@ast
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@en
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@nl
type
label
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@ast
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@en
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@nl
prefLabel
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@ast
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@en
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@nl
P2860
P3181
P356
P1433
P1476
Contact lens-related microbial ...... h pathogenesis and prophylaxis
@en
P2093
F Stapleton
P2860
P2888
P304
P3181
P356
10.1038/EYE.2011.288
P407
P50
P577
2012-02-01T00:00:00Z
P5875
P6179
1020158017